Barbara Sommer

Publications

• Review of topiramate for the treatment of epilepsy in elderly patients. Sommer BR, Fenn HH. Clin Interv Aging. 2010: 5 89-99
• Treatment-resistant major depression and the capacity to terminate care Sommer BR, Journal of Ethics in Mental Health. 2010; 5 (1): 1-4
• The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome Kishnani PS, Sommer BS, Handen BL, Seltzer B, Capone GT, et al. Am J Med Genetics. 2009; 149A (8): 1641-1654
• Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele. O'Hara R, Sommer B, Way N, Kraemer HC, Taylor J, Murphy G. J Psychiatr Res. 2008; 42 (3): 199-204
• Role of psychiatric comorbidity on cognitive function during and after the menopausal transition Alexander JL, Sommer BR. Expert Rev Neurotherapeutics. 2007; 7 (11): S155
• Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin. Sommer BR, Fenn HH, Ketter TA. Expert Opin Drug Saf. 2007; 6 (2): 133-45
• Safety and tolerability of mood-stabilizing anticonvulsants in elderly Fenn HH, Sommer BR, Ketter TA, Alldredge B. Expert Opin Drug Saf. 2006; 5 (3): 401
• The effect of oxybutynin treatment on cognition in children with diurnal incontinence. Sommer BR, O'Hara R, Askari N, Kraemer HC, Kennedy WA. J Urol. 2005; 173 (6): 2125-7
• Orange juice-induced hyperkalemia in schizophrenia Berk DR, Conti PM, Sommer BR. Int J of Psychiatry in Medicine. 2004; 34 (1): 79
• Folic acid supplementation in dementia: a preliminary report. Sommer BR, Hoff AL, Costa M. J Geriatr Psychiatry Neurol. 2003; 16 (3): 156-9
• Safety of antidepressants in the elderly. Sommer BR, Fenn H, Pompei P, DeBattista C, Lembke A, Wang P, Flores B. Expert Opin Drug Saf. 2003; 2 (4): 367-83
• Gingko biloba and related compounds in Alzheimer’s disease Sommer BR, Schatzberg AF. Psychiatric Annals. 2002; 32 (1): 13-18
• Is dopamine administration possibly a risk factor for delirium? Sommer BR, Wise LC, Kraemer HC. Crit Care Med. 2002; 30 (7): 1508-11
• Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression. Thompson LW, Coon DW, Gallagher-Thompson D, Sommer BR, Koin D. Am J Geriatr Psychiatry. 2001; 9 (3): 225-40
• Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report. Sommer BR, J Geriatr Psychiatry Neurol. 2001; 14 (2): 99-100
• Naturalistic study of antipsychotic medications prescribed to elderly schizophrenic patients Sommer BR, White L, Parrella M, Harvey PD, Knobler HY, Powchick P, Masiar SJ. Jrnl Prac Psych and Behav Hlth. 1998; 4 (6): 379
• Risperidone: Clinical outcome predictors and cost-effectiveness in a naturalistic setting Finley PR, Sommer BR, Corbitt JL, Brunson GH, Lum BL. Psychopharmacology Bull. 1998; 34 (1): 75-81
• Divalproex sodium for treatment of agitation in chronic psychiatric inpatients Sommer BR, White L, Parrella M, Simon JM, Masiar SJ. Jrnl Prac Psych and Behav Hlth. 1997; 3 (5): 320
• Syndrome of inappropriate antidiuretic hormone (SIADH) in an 80-year-old woman given clomipramine. Sommer BR, Am J Geriatr Psychiatry. 1997; 5 (3): 268-9
• Changes in tardive dyskinesia symptoms in elderly patients treated with ganglioside GM1 or placebo. Sommer BR, Cohen BM, Satlin A, Cole JO, Jandorf L, Dorsey F. J Geriatr Psychiatry Neurol. 1994 Oct-Dec; 7 (4): 234-7
• A case of baclofen-induced psychotic depression Sommer BR, Petrides G. J Clin Psychiatry. 1992: 53 211-212
• Glycopyrrolate versus atropine in post-ECT amnesia in the elderly Sommer BR, Satlin A, Friedman L, Cole JO. J Geriatric Psychiatry and Neurology. 1989: 2 18-21
• Metabolism of thioridazine in the elderly. Cohen BM, Sommer BR. J Clin Psychopharmacol. 1988; 8 (5): 336-9
• RBC folic acid levels and cognitive performance in elderly patients: a preliminary report. Sommer BR, Wolkowitz OM. Biol Psychiatry. 1988; 24 (3): 352-4
• Plasma concentration of neuroleptic and serum prolactin in patients chronically receiving depot fluphenazine: No evidence of tolerance Cohen BM, Chouinard G, Waternaux C, Schachter H, Jones B, Sommer BR. Human Psychopharmacology. 1987: 2 171-176
• Plasma levels of neuroleptic in patients receiving depot fluphenazine. Cohen BM, Waternaux C, Chouinard G, Sommer BR, Jones B. J Clin Psychopharmacol. 1985; 5 (6): 328-32
• Circadian changes in the destruction and effects of haloperidol in the rat. Campbell A, Herschel M, Sommer B, Madsen JR, Cohen BM, Baldessarini RJ. Neuropharmacology. 1982; 21 (7): 663-9